Industry News
Boosting Body's Natural Tumor-Fighting Protein May Aid Cancer Treatment
Feb 11, 2013
New research from the US suggests it may be possible boost a natural tumor-fighting protein that is already present in the body's immune system to enhance the effectiveness of cancer treatment, especially for advanced cancers that are difficult to treat... Read More
For Kidney Disease Patients, Frequent Treatments Improve Health But Increase Risks For Certain Complications
Feb 11, 2013
Compared with standard dialysis, frequent dialysis can cause complications related to repeated access to the blood, requiring patients to undergo more repair procedures to the site through which blood is removed and returned, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN)... Read More
Exercise Linked With Reduced Prostate Cancer Risk In Caucasians But Not African Americans
Feb 11, 2013
A new study suggests that exercise may reduce Caucasian men's risk of developing prostate cancer. And among Caucasian men who do have prostate cancer, exercise may reduce their risk of having more serious forms of the disease. Unfortunately, the benefits do not seem to apply to African- American men... Read More
Study Using Cells Forged From Human Skin Shows Promise In Treating MS, Myelin Disorders
Feb 11, 2013
A study out today in the journal Cell Stem Cell shows that human brain cells created by reprogramming skin cells are highly effective in treating myelin disorders, a family of diseases that includes multiple sclerosis and rare childhood disorders called pediatric leukodystrophies... Read More
Pomalyst (pomalidomide) For Advanced Multiple Myeloma Approved By FDA
Feb 11, 2013
Pomalyst (pomalidomide) has been approved by the FDA for the treatment of patients with multiple myeloma whose cancer progressed after being treated with other medications. Pomalyst, which is presented in capsule form, modulates the immune system so that the patient's own body destroys cancerous cells and undermines their growth... Read More
Exercise Linked With Reduced Prostate Cancer Risk In Caucasians But Not African Americans
Feb 11, 2013
A new study suggests that exercise may reduce Caucasian men's risk of developing prostate cancer. And among Caucasian men who do have prostate cancer, exercise may reduce their risk of having more serious forms of the disease. Unfortunately, the benefits do not seem to apply to African- American men... Read More
Pomalyst (pomalidomide) For Advanced Multiple Myeloma Approved By FDA
Feb 11, 2013
Pomalyst (pomalidomide) has been approved by the FDA for the treatment of patients with multiple myeloma whose cancer progressed after being treated with other medications. Pomalyst, which is presented in capsule form, modulates the immune system so that the patient's own body destroys cancerous cells and undermines their growth... Read More
Study Using Cells Forged From Human Skin Shows Promise In Treating MS, Myelin Disorders
Feb 11, 2013
A study out today in the journal Cell Stem Cell shows that human brain cells created by reprogramming skin cells are highly effective in treating myelin disorders, a family of diseases that includes multiple sclerosis and rare childhood disorders called pediatric leukodystrophies... Read More
IBM Supercomputer "Watson" To Help In Cancer Treatment
Feb 10, 2013
Oncologists hope that IBM's Watson supercomputer can help them improve the speed and efficacy of cancer treatments, IBM announced. Two years ago, "Watson" beat all-time Jeopardy! champions. Dr... Read More
Nanoscale Vehicle Created To Battle Cancer Without Harming Healthy Cells
Feb 10, 2013
Devising a method for more precise and less invasive treatment of cancer tumors, a team led by researchers from the UCLA Henry Samueli School of Engineering and Applied Science has developed a degradable nanoscale shell to carry proteins to cancer cells and stunt the growth of tumors without damaging healthy cells... Read More
Previous Page Next Page